Target intelligence / Profile preview

Actin cytoskeleton

Molecular classification
Other (cytoskeletal protein assembly), Actin filament, Microfilament
01

Overview

The **actin cytoskeleton** is a dynamic intracellular network of actin filaments (microfilaments), assembled from globular actin (G-actin) polymerized into filamentous actin (F-actin). It provides structural support, maintains cell shape, and enables a wide array of cellular processes such as division, motility, muscle contraction, and intracellular transport. The actin cytoskeleton is regulated by various actin-binding proteins that control filament assembly, organization, and disassembly[1][2][4][8]. Changes in actin cytoskeletal dynamics underpin essential biology and are involved in many pathologies, but as a network rather than a discrete molecular entity, it is not a canonical drug target but serves as a central hub in cell biology. For future structured data, individual components (e.g., actin itself, Arp2/3 complex, or specific actin isoforms) should be considered as molecular targets rather than the entire cytoskeletal system[1][5].

Other names
Actin filament networkMicrofilament systemF-actin network
02

Mechanism of action

Inhibition of actin polymerization or depolymerization. Stabilization or disruption of actin filaments. Modulation of actin-binding protein function[4]

03

Biological functions

Cell shape maintenance[1][2][4][8]Cell motility and migration[1][2][4][8]Muscle contraction[1][8]Cytokinesis and cell division[1][2][8]Vesicle/organelle transport[1][4]Signal transduction[1]Mechanosensation[4]
04

Disease associations

Cancer (cell migration, invasiveness)[4]Muscular diseases and myopathies[1]Neurodegenerative disorders (neuronal polarity, dendritic spine function)[3]Cardiovascular disease (muscle contractility)[1]Infection (cell shape and motility influence pathogen invasion)[1]
05

Safety considerations

Global disruption of actin cytoskeleton causes cytotoxicity and impaired cell division, motility, and viability[4]Muscle-specific toxicity (e.g., rhabdomyolysis, cardiac impairment)[1]Immunocompromise due to effects on cell movement and immune cell activation[1][4]Off-target effects due to broad expression in all eukaryotic cells[1]
06

Interacting drugs

Cytochalasins (disrupt filament formation)

4 more in the full profile.

07

Biomarkers

F-actin/G-actin ratio (indicator of cytoskeletal integrity, cell state)[4]Actin mutation (diagnostic for skeletal myopathies)[1]Expression of actin-binding proteins (profilin, cofilin, Arp2/3 etc.)[4][5]

Beyond the preview

Go deeper on Actin cytoskeleton.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin cytoskeleton.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call